The global female pelvic implants industry size is forecasted to expand at 2.8% CAGR over the estimated period, as per FMI’s analysis. The industry’s size is predicted to reach a market value of US$ 258.91 million in 2023, and reaching US$ 341.26 million by 2033.
Increasing cases of stress urinary incontinence (SUI) and pelvic organic prolapse (POP) among women are propelling the demand for female pelvic implants. These conditions are the cause of obesity, aging, and childbirth. The Association for Pelvic Organ Prolapse Support (APOPS) records almost 300,000 surgeries for POP in the United States per year.
To Get The Sample Copy Of Report Visit! https://www.futuremarketinsights.com/reports/sample/rep-gb-3422
The design and materials of these implants are constantly optimized for better outcomes and lowered complications, thus fueling their demand. Making mesh materials with a reduced likelihood of any adverse effect is surging the acceptance of these devices among end users.
Growing responsiveness for pelvic floor disorders and cognizance about different treatment options among females is pushing the market development. As a result, the quantity of pelvic implant procedures is increasing.
Childbirth often results in trauma to ligaments and muscles. Disruption in hormonal cycles due to menopause also causes muscle weakening and loss of elasticity. Besides, heavy lifting also causes injury to pelvic organs and results in prolapse.
POP also can be genetically transferred and is commonly seen in overweight women. Women with such symptoms are recommended reconstructive surgery with vaginal mesh. Even though it is deemed that pelvic implants can treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP) effectively, they can also lead to complications like erosion, infection, and pain. Such adverse effects can dissuade women from getting this procedure.
Non-surgical treatments like medication and pelvic floor muscle exercises are available for stress urinary incontinence and pelvic organ prolapses. Many women are likely to opt for these solutions over surgery. Consequently, limiting the market growth.
Side effects of present treatments, the high cost of implants, and laborious regulatory procedures may impede the overall growth of the market.
Top Highlights from the FMI’s Analysis of the Female Pelvic Implants Market:
- Presently, the United States female pelvic implants industry holds more than 83% of North America market.
- In Europe region, the United Kingdom accounts for 13% of the regional market.
- India market registered sales exceeding 30% of South Asia.
- Australia’s market for female pelvic implants is projected to exhibit a 2.8% CAGR over the forecast period.
- The vaginal sling/ tapes are projected to expand at a CAGR of 2.5% over the forecast period.
- Scope of sale in hospitals is projected to expand at a CAGR of 2.2% in the following years.
Our Analyst Is Here To Assist You With Any Questions Get In Touch Now! https://www.futuremarketinsights.com/ask-question/rep-gb-3422
How are Leading Companies Striving Forward?
The competitive space in the market is governed by organic as well as inorganic expansion strategies. Many companies in the market are concentrating their efforts on product releases, approvals, and others like events and patents.
Inorganic growth-inducing activities include partnerships, acquisitions, and collaborations. Such activities have created a pathway for companies to increase their customers and business in the following years.
In November 2023, CurvaFix, Inc., a manufacturer of medical devices to treat fractures in curved bones, revealed the launch of the 7.5mm CurvaFix® IM Implant. The product is designed to ease the process of surgery and offer a stable, strong, and curved fixation in patients with small bones.
Key Players Working in the Market:
- Johnson & Johnson Services, Inc.
- Coloplast A/S
- Dipromed Srl
- Boston Scientific Corporation
- pfm medical ag
- Betatech Medical
- Promedon Group
- Caldera Medical
- Cook Medical
Ignite Innovation with Customization: Uncover the Possibilities in Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-3422
Market Taxonomy by Category:
By Product Type:
- Vaginal Mesh Implants
- Vaginal Sling
- Vaginal Graft Implants
By Indication:
- Pelvic Organ Prolapse
- Stress Urinary Incontinence
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
By Region:
- North America
- Latin America
- China
- Western Europe
- Eastern Europe
- Asia Pacific
- The Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube